Literature DB >> 10696560

Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.

D S Nieves1, E E Bondi, J Wallmark, E C Raps, J T Seykora.   

Abstract

Scleromyxedema is a rare systemic disorder characterized by cutaneous sclerosis and papulosis, accompanied by deposition of mucin in the skin and other organs. We describe a case of scleromyxedema in a 62-year-old man. The cutaneous symptoms of the disorder were preceded by episodes of acute central nervous system dysfunction that included mental confusion, hemiparesis, tremor, and migraine. As the cutaneous symptoms progressed, the patient experienced persistent confusion and difficulty concentrating. Therapy with melphalan and plasmapheresis led to complete resolution of the cutaneous symptoms as well as near-resolution of the neurologic symptoms. This is the first report to describe the successful treatment of the cutaneous symptoms of scleromyxedema accompanied by reversal of chronic neurologic dysfunction.

Entities:  

Mesh:

Year:  2000        PMID: 10696560

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

1.  Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.

Authors:  Michele L Donato; Adrienne M Feasel; Donna M Weber; Victor G Prieto; Sergio A Giralt; Richard E Champlin; Madeleine Duvic
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

Review 2.  Scleroderma-like cutaneous syndromes.

Authors:  Yasuji Mori; Veli-Matti Kahari; John Varga
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 3.  Scleroderma-like fibrosing disorders.

Authors:  Francesco Boin; Laura K Hummers
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.